The Bulletin
The Times


.

Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine

  • Written by The Bulletin

ROCHESTER, MINN., US / SINGAPORE – Media OutReach Newswire – 23 September 2026 – Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand.

Read more: Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance...

hacklink esim balkanSahabetmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopgrandpashabet resmi girişjojobet